FDA Approved: DECITABINE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for decitabine from Accord Healthcare Inc. under an ANDA, marking an updated approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)

Snippet

SUPPL AP for DECITABINE (DECITABINE)